tetradecanoylphorbol acetate has been researched along with Purpura, Thrombotic Thrombocytopenic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costello, C; Kim, J; Laurence, J; Mauro, M | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Purpura, Thrombotic Thrombocytopenic
| Article | Year |
|---|---|
Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
Topics: Apoptosis; Cell Cycle; Cell Lineage; Cells, Cultured; Coronary Vessels; Culture Media, Serum-Free; Endothelium, Vascular; Extracellular Matrix Proteins; Fibronectins; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Liver; Organ Specificity; Palatine Tonsil; Platelet Aggregation Inhibitors; Platelet Count; Purpura, Thrombotic Thrombocytopenic; RNA, Messenger; Skin; Tetradecanoylphorbol Acetate; Thrombospondins; Ticlopidine; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2001 |